Covered Stocks

Justin Zelin

Work

Analyst Justin Zelin works at BTIG and is focused on the Healthcare sector with 18 price targets and ratings documented since 2020 spanning on 7 stocks. Analyst's average stock valuation to be materialised ratio is 26.67% with an average time for price targets to be met of 51.8 days.

Most recent stock forecast was given on MBIO, Mustang Bio, Inc at 16-Nov-2022.

Justin Zelin best performing recommendations are on ABEO (ABEONA THERAPEUTICS INC).
The best stock recommendation documented was for ABEO (ABEONA THERAPEUTICS INC) at 9/29/2020. The price target of $50 was fulfilled within 112 days with a profit of $22.25 (80.18%) receiving and performance score of 7.16.

Average potential price target upside

ABEO ACET BLU LEGN MBIO CASI PSTX
ABEO ACET BLU LEGN MBIO CASI PSTX